Leading Forward
The CEO Council for Growth (CEO Council) leads our region forward by envisioning a stronger, more competitive community, convening decision makers, taking action, and advocating for policies and practices that strengthen our regional economy.
Leading Forward
The CEO Council for Growth (CEO Council) leads our region forward by envisioning a stronger, more competitive community, convening decision makers, taking action, and advocating for policies and practices that strengthen our regional economy.
PRIORITIES
INNOVATION
Our innovation agenda seeks to leverage Greater Philadelphia’s strengths to build a vibrant economy that supports research and development, commercialization, and entrepreneurship which will position our region for accelerated company and job growth.
REGIONAL MOBILITY
Our mobility agenda seeks to improve our region’s physical connectivity by advocating for infrastructure improvements to ensure a modern, multimodal transportation system.
TALENT
The core principles of our talent agenda focus on enhancing the region’s pipeline of innovative talent to improve Greater Philadelphia’s competitive position.
MEMBERS
Engaged regional business leadership is critical for Greater Philadelphia to compete in a global economy. Our team of more than 60 devoted business, higher education, and civic leaders commit their time and efforts to define our competitive advantage and drive economic growth.
ALI A. HOUSHMAND, PH.D.
President
Rowan University
CHRISTOPHER GHEYSENS
President & Chief Executive Officer
Wawa
DARIO C. ALTIERI, M.D.
President & Chief Executive Officer
The Wistar Institute
MATTHEW A. TAYLOR, ESQUIRE
Chairman & Chief Executive Officer
Duane Morris LLP
NICOLE J. TRANCHITELLA
Senior Managing Director
Accenture LLC
ROBERT DELANY
Chief Financial Officer
PFM Asset Management LLC
THOMAS J. HOLT, JR.
Owner
Holt Logistics Corp.
WILLIAM J. MARRAZZO
President & Chief Executive Officer
WHYY, Inc.
News
Robust Investment in Greater Philadelphia Region’s Cell and Gene Therapy Sector Continued in the First Quarter of 2021
Among the life sciences deals for the first quarter of 2021 were nine transactions in the cell and gene therapy space totaling more than $980 million.
Science Center Launches Global Accelerator Program Focused on Cell and Gene Therapy
Seven Canadian companies are participating in the six-week online program, which assists businesses interested in entering the U.S. market with advice, mentorship, and access to a network of industry leaders.
Big4Bio Philadelphia 2021 Outlook
The critically important work of the life sciences industry globally has been front and center as health care providers, researchers, manufacturers and distributors collaborate to respond to the coronavirus pandemic.